At AdvaMed’s The MedTech Conference, CEOs from top medical device companies shared how they navigate difficult times, ...

Medtronic said Monday it has received a CE mark for its Vitalis portfolio of cardiac pacemakers. The portfolio features five ...

ResMed CEO Mick Farrell, chair of AdvaMed’s board, said the group plans to come up with standards around privacy, ...

BOSTON — In an era of heightened tariff volatility and geopolitical risk, medtech companies are rewriting their supply chain ...

Facing continued softness, Intuitive outlined opportunities to increase use of its robots in benign general surgeries.

Quest Diagnostics is the latest medtech company to disclose that it was hit by a cyberattack. The testing services company identified unauthorized access to its Quanum Lab Services Manager system on ...

BOSTON — The Food and Drug Administration’s medical device center has lost a significant number of staff following massive cuts at the start of the Trump administration. The regulator is now looking ...

Grail’s multicancer detection test could soon become the first blood test of its kind to secure Food and Drug Administration approval. The Galleri test screens for many types of cancer from one blood ...

The Food and Drug Administration said Tuesday it is preventing five more models of Olympus endoscopes manufactured in Japan from being shipped into the U.S., adding to a list of 58 devices already ...

BOSTON — Rick Abramson, director of the Food and Drug Administration’s Digital Health Center of Excellence, said to expect draft guidance on generative artificial intelligence in the coming months at ...

Abbott is the latest major medtech company to turn to the spinout strategy. Medtronic separated its diabetes business earlier this year, and Johnson & Johnson is planning to spin out its orthopedics ...